Enosis Therapeutics was formed to launch the synergistic use of psychedelic psychotherapy and virtual reality. Carefully designed clinical protocols employ targeted virtual reality scenarios at specific points of psychedelic-assisted psychotherapy, to improve the quality of the patient experience by allowing modulation of both internal and external factors. Enosis introduces clinical protocols and wondrous VR scenarios into clinical trials to strengthen psychedelic research, and curate therapeutic sessions.
Team
Prashanth Puspanathan
Co-Founder
A tale of two hats:
Chapter 1: Dr. Prash P is the founder and chairman of Caleb & Brown, the world’s leading personalised cryptocurrency brokerage. Since 2016, the firm has helped over 29,000 clients in more than 100 countries navigate the complexities of digital asset investment, offering a 24/7 personal broker model that brings trust and accessibility to an often chaotic space.
In 2018, Caleb & Brown was awarded Fintech Startup of the Year by the Stockbrokers and Financial Advisors Association for bridging the divide between traditional financial services and the fast-evolving crypto ecosystem. Prash remains a vocal advocate for modernising legacy financial systems—firm in his belief that settlement standards like “T+2” no longer belong in the digital age.
That same year, he was recognised as Young Executive of the Year by the Australian Indian Executive Council for his leadership across sectors.
Chapter 2:
A consultant psychiatrist by training, Prash holds a Bachelor of Medicine and Bachelor of Surgery (Honours) from Monash University, and a Master of Psychological Medicine from the University of Melbourne. Prash completed his clinical training at The Alfred Hospital in Melbourne with a clear goal: to contribute meaningfully to the future of mental health through psychedelic-assisted psychotherapy.
He is the co-founder of Enosis Therapeutics, a company pioneering Spatial Therapeutics (STx)—a new therapeutic framework that combines Virtual Reality with psychedelic-assisted therapy. Enosis holds an Australian Innovation Patent for its protocol, and is at the forefront of exploring how technology can enhance altered-state therapies in meaningful, grounded ways.
In parallel, Prash supports early-stage psychedelic ventures, guided by the belief that thoughtful, ethical investment can help shape the sector with integrity. His advocacy against myth, misconception and stigma in the face of evidence persists, despite the ire of his mother.
The Close
His discourses and writings on both his passions are freely available via his non-exclusive, open-source, failure-to-opt-out partnership with Google.
(And no, he doesn’t offer crypto tips or trial sign-ups via LinkedIn.)
